TY  - GEN
AU  - Xu,Jian-Ming
AU  - Azzariti,Amalia
AU  - Colucci,Giuseppe
AU  - Paradiso,Angelo
TI  - The effect of gefitinib (Iressa, ZD1839) in combination with oxaliplatin is schedule-dependent in colon cancer cell lines
SN  - 0344-5704
PY  - 2003///1224
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - pharmacology
KW  - Apoptosis
KW  - drug effects
KW  - Blotting, Western
KW  - Cell Line, Tumor
KW  - Cell Survival
KW  - Colonic Neoplasms
KW  - pathology
KW  - DNA Adducts
KW  - Dose-Response Relationship, Drug
KW  - Drug Evaluation, Preclinical
KW  - Gefitinib
KW  - HT29 Cells
KW  - Humans
KW  - Inhibitory Concentration 50
KW  - Organoplatinum Compounds
KW  - administration & dosage
KW  - Oxaliplatin
KW  - Precipitin Tests
KW  - Quinazolines
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1007/s00280-003-0687-8
ER  -